New Truehope Nutritional Support Research just out
Does EMPowerplus sound familiar? It is Truehope Nutritional Support Ltd's revolutionary micronutrient treatment developed to address the symptoms of mental illnesses such as bipolar affective disorder, depression, schizophrenia, attention deficit disorder and other central nervous system disorders. This is also the company that Health Canada is bound and determined to thwart, take to court and discredit. Thousands of people with mental illnesses now depend on EMPowerplus to effectively control their symptoms, without significant side effects.To them EMPowerplus is a lifeline that is always on the edge of being removed from them.
Since 1996, scientific researchers and doctors in clinical practice have been studying the effects of EMPowerplus on mental disorders such as bipolar disorder. These studies were not funded by the company, Truehope, which is non-profit. Although the sample sizes were small, the results have been very encouraging and significant. In all of the published studies, more than 80 percent of the participants saw a major improvement in symptoms. By comparison, only a fraction of people who are prescribed psychiatric drugs show improvement.
Dr. Bonnie Kaplan, a respected behavioural research scientist and one of the principle researchers on several of the published studies says, “If substantiated in controlled trials, the normalization of the mentally ill via nutrient supplementation would be the most significant breakthrough in the field of mental illness since the beginning of time.”
Here follows the latest results just out:
A new scientific study led by researchers at New York University and the University of Calgary reveals long-term benefits of a broad-based micronutrient treatment for bipolar disorder (Clinical Medicine: Psychiatry, 2009, 4:3-16; http://la-press.com/article.php?article_id=1384) April 1, 2009
Key Findings
• In a large sample of 358 adults with bipolar disorder, the effect size was large at 6 months (0.76, p < 0.001).
• For over half the sample, symptom improvement exceeded 50% at 3 and 6 months.
• One-third of the sample experienced very significant symptom reduction that exceeded 75%.
• The strongest predictors of improved mental health were (a) increasing micronutrient dose and (b)
decreasing psychiatric medications.
Study Aims
Because of the incomplete benefit from pharmaceuticals and from single nutrient interventions in treating
mood symptoms, and the more promising results from multinutrient formulas, the authors investigated the long term
benefits of a broad-based micronutrient formula.
Data Source
The data was obtained from individuals who purchased a micronutrient formula and provide self reported
symptom data to the product developers. The database used was anonymous, using assigned identifier numbers.
The sample consisted of 682 adults who reported being diagnosed with bipolar disorder. Within that group, 358
individuals reported the single diagnosis of bipolar disorder and provided symptom data for at least 6 months worth of
analysis. Neither author was involved in any way with the data collection and could not bias the data in any way.
Results
The analysis showed that not only was the use of the micronutrient formula linked to the outcome but the
amount of formula taken (measured in capsules) was directly proportional to the outcome.
Individuals taking medications also experienced significant decreases in symptoms; however, the group with
the higher medication index had the more moderate response, and while maintaining the improvement, did not
improve like the other groups did.
The fact that symptom improvements were sustained or even increased at 6 months strongly suggests that
the benefit cannot be attributed to a placebo effect.
Selecting for the single disorder makes the participants, and results, comparable to those who are in typical
pharmaceutical trials.
People searching for nutritional methods to manage their mood symptoms are likely to have had ineffective
experience with medications, and perhaps be considered treatment resistant. While not representative of everyone
with bipolar disorder it is possible that they are more difficult to treat, lending more weight to the clinical implications
of these findings.
With the emergent evidence of the modest effect of pharmaceuticals and the growing evidence for the
improving of mood symptoms using multinutrient formulas, this evidence provides a powerful case for further
research with this type of intervention.
This brings to 6 the number of published articles demonstrating reproducibility and efficacy of the Truehope
multinutrient formula.
Truehope Nutritional Support Ltd., 1-888-TRUEHOPE (1-888-878-3467), help@truehope.com and www.truehope.com
